Skip to main content

Gut Microbiota as Signatures in Non-communicable Diseases and Mucosal Immunity

  • Chapter
  • First Online:
Theranostics Approaches to Gastric and Colon Cancer

Abstract

The human gut microbiota encompasses a complex and dynamic ecosystem that provides crucial signals for host development and physiology. The altering composition of the human microbiota is associated with modifications in human behavior and the rising prevalence of pathogenesis of late onset diseases such as life style non-communicable diseases, metabolic and neurological disorders etc. The factors that trigger modifications in the composition and function of the gut microbiota will aid in understanding and designing of therapies that target it, which may be quite formidable. Though several studies have been reported on altered gut microbial composition and its association with diseases, but information on mucin layer degradation, production and immune cell interactions is scanty. The alignment of the gut microbiota can be an emerging indicator or marker of health, as it could be a sensitive tool for identifying various risks. This review unzips the role and type of gut microbiota associated with different non-communicable diseases and their impact on intestinal mucosal immunity which could be the signatures required to promote the human health by the clinicians.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AD:

Alzheimer’s disease

AD:

Auto immune disease

ADD:

Antibiotic associated diarrhoea

ALS:

Amyotrophic lateral sclerosis

ASD:

Autism spectrum disorder

BBDP:

Bio breeding diabetes prone

BMI:

Body mass index

CD:

Chron’s disease

CHF:

Chronic heart failure

CKD:

Chronic kidney disease

CNS:

Central nervous system

CRC:

Colorectal Cancer

CVD:

Cardio vascular disease

EU:

Endotoxin Unit

GFD:

Gluten free diet

GH:

Glycoside hydrolases

GIT:

Gastro intestinal tract

GM:

Germ free

GPR:

G protein coupled receptor

GWAS:

Genome wide association studies

HBV:

Hepatitis B Virus

HCC:

Hepatocellular carcinoma

HCV:

Hepatitis C Virus

HP:

Helicobacter pylori

HPV:

Human Papilloma Virus

IAP:

Inhibitor of apoptosis protein

IBD:

Inflammatory bowel diseases

IBS:

Irritable bowel syndrome

Ig:

Immunoglobulin

LDL:

Low density lipoprotein

LPS:

Lipopolysaccharide

NAFLD:

Nonalcoholic fatty liver diseases

NASH:

Nonalcoholic steatohepatitis

NCD:

Non communicable disease

NFT:

Neuro fibrillary tangles

NOD:

Non obese diabetic

PAMP:

Pathogen associated molecular patterns

PD:

Parkinson’s diseases

PDD:

Pervasive developmental disorder

PPAR:

Peroxisome proliferator activated receptor

PRR:

Pattern recognition receptor

PSE:

Plant sterol esters

RA:

Rheumatoid arthritis

SCFA:

Short chain fatty acid

SLE:

Systemic lupus erythematosus

SNP:

Single nucleotide polymorphism

T1D:

Type 1 diabetes

T2D:

Type 2 diabetes

TLR:

Toll like receptor

TMA:

Trimethylamine

TRL:

Triglyceride rich lipoprotein

UC:

Ulcerative colitis

WHO:

World health organization

References

  • Aguirre M, Venema K (2015) Does the gut microbiota contribute to obesity? Going beyond the gut feeling. Microorganisms 3(2):213–235

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, Goedert JJ, Hayes RB, Yang L (2013) Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 105(24):1907–1911

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ahrne S, Johansson Hagslatt M-L (2011) Effect of lactobacilli on paracellular permeability in the gut. Nutrients 3(1):104–117

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Álvarez-Arellano L, Maldonado-Bernal C (2014) Helicobacter pylori and neurological diseases: married by the laws of inflammation. World J Gastrointest Pathophysiol 5(4):400

    Article  PubMed  PubMed Central  Google Scholar 

  • Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, Chamontin B, Ferriéres J (2008) Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 87(5):1219–1223

    Article  CAS  PubMed  Google Scholar 

  • Andoh A, Kuzuoka H, Tsujikawa T, Nakamura S, Hirai F, Suzuki Y, Matsui T, Fujiyama Y, Matsumoto T (2012) Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease. J Gastroenterol 47(12):1298–1307

    Article  PubMed  Google Scholar 

  • Angelberger S, Reinisch W, Makristathis A, Lichtenberger C, Dejaco C, Papay P, Novacek G, Trauner M, Loy A, Berry D (2013) Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol 108(10):1620

    Article  CAS  PubMed  Google Scholar 

  • Anstee QM, McPherson S, Day CP (2011) How big a problem is non-alcoholic fatty liver disease? BMJ 343:d3897

    Article  PubMed  Google Scholar 

  • Artis D (2008) Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 8(6):411–420

    Article  CAS  PubMed  Google Scholar 

  • Atkinson M, Chervonsky A (2012) Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia 55(11):2868–2877

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bach J-F (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347(12):911–920

    Article  PubMed  Google Scholar 

  • Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci 101(44):15718–15723

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bakken J, Borody T, Brandt L, Brill J, Demarco D, Franzos M, Kelly C, Khoruts A, Louie T, Martinelli L et al (2011) Treating Clostridium difficile infection with fecal microbiota transplantation. Clinical Gastroenterol hepatol: official Clin Pract J Am Gastroenterol Assoc 9:1044–1049

    Article  Google Scholar 

  • Balin BJ, Hudson AP (2014) Etiology and pathogenesis of late-onset Alzheimer’s disease. Curr Allergy Asthma Rep 14(3):417

    Article  PubMed  Google Scholar 

  • Banjoko IO, Adeyanju MM, Ademuyiwa O, Adebawo OO, Olalere RA, Kolawole MO, Adegbola IA, Adesanmi TA, Oladunjoye TO, Ogunnowo AA (2012) Hypolipidemic effects of lactic acid bacteria fermented cereal in rats. Lipids Health Dis 11(1):170

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Baumgart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, Yantiss R, Orsi RH, Wiedmann M, McDonough P, Kim SG et al (2007) Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of clostridiales in Crohn’s disease involving the ileum. ISME J 1(5):403–418

    Article  CAS  PubMed  Google Scholar 

  • Behera SK, Praharaj AB, Dehury B, Negi S (2015) Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases. Glycoconj J 32(8):575–613

    Article  CAS  PubMed  Google Scholar 

  • Bekkering P, Jafri I, Van Overveld FJ, Rijkers GT (2013) The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes. Expert Rev Clin Immunol 9(11):1031–1041

    Article  CAS  PubMed  Google Scholar 

  • Belmonte L, Youmba SB, Bertiaux-Vandaele N, Antonietti M, Lecleire S, Zalar A, Gourcerol G, Leroi A-M, Déchelotte P, Coëffier M (2012) Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype. PLoS One 7(8):e42777

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, Nikkïla J, Monti D, Satokari R, Franceschi C (2010) Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 5(5):e10667

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Blaecher C, Smet A, Flahou B, Pasmans F, Ducatelle R, Taylor D, Weller C, Bjarnason I, Charlett A, Lawson A (2013) Significantly higher frequency of H elicobacter suis in patients with idiopathic parkinsonism than in control patients. Aliment Pharmacol Ther 38(11–12):1347–1353

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Boesten RJ, de Vos WM (2008) Interactomics in the human intestine: lactobacilli and bifidobacteria make a difference. J Clin Gastroenterol 42:S163–S167

    Article  PubMed  Google Scholar 

  • Boursier J, Diehl AM (2015) Implication of gut microbiota in nonalcoholic fatty liver disease. PLoS Pathog 11(1):e1004559

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brandl K, Schnabl B (2017) Intestinal microbiota and nonalcoholic steatohepatitis. Curr Opin Gastroenterol 33(3):128–133

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brown K, DeCoffe D, Molcan E, Gibson DL (2012) Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 4(8):1095–1119

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bull TJ, McMinn EJ, Sidi-Boumedine K, Skull A, Durkin D, Neild P, Rhodes G, Pickup R, Hermon-Taylor J (2003) Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn’s disease. J Clin Microbiol 41(7):2915–2923

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Burrows MP, Volchkov P, Kobayashi KS, Chervonsky AV (2015) Microbiota regulates type 1 diabetes through toll-like receptors. Proc Natl Acad Sci U S A 112(32):9973–9977

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C et al (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56(7):1761–1772

    Article  CAS  PubMed  Google Scholar 

  • Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet–induced obesity and diabetes in mice. Diabetes 57(6):1470–1481

    Article  CAS  PubMed  Google Scholar 

  • Cani PD, Daubioul CA, Reusens B, Remacle C, Catillon GG, Delzenne NM (2005) Involvement of endogenous glucagon-like peptide-1(7–36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. J Endocrinol 185(3):457

    Article  CAS  PubMed  Google Scholar 

  • Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ (2015) Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis 26:26191–26191

    PubMed  Google Scholar 

  • Caselli M, Cassol F, Calò G, Holton J, Zuliani G, Gasbarrini A (2013) Actual concept of “probiotics”: is it more functional to science or business? World J Gastroenterol: WJG 19(10):1527

    Article  PubMed  PubMed Central  Google Scholar 

  • Cenit MC, Olivares M, Codoñer-Franch P, Sanz Y (2015) Intestinal microbiota and celiac disease: cause, consequence or co-evolution? Nutrients 7(8):6900–6923

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55(6):2005–2023

    Article  PubMed  Google Scholar 

  • Cheng J, Palva AM, de Vos WM, Satokari R (2011) Contribution of the intestinal microbiota to human health: from birth to 100 years of age. In: Between pathogenicity and commensalism. Springer, Berlin, Heidelberg, pp 323–346

    Google Scholar 

  • Clarke JL, Daniell H (2011) Plastid biotechnology for crop production: present status and future perspectives. Plant Mol Biol 76(3–5):211–220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Collado MC, Isolauri E, Laitinen K, Salminen S (2008) Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 88(4):894–899

    Article  CAS  PubMed  Google Scholar 

  • Collins M, Lawson P, Willems A, Cordoba J, Fernandez-Garayzabal J, Garcia P, Cai J, Hippe H, Farrow J (1994) The phylogeny of the genus clostridium: proposal of five new genera and eleven new species combinations. Int J Syst Evol Microbiol 44(4):812–826

    CAS  Google Scholar 

  • Cope K, Risby T, Diehl AM (2000) Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 119(5):1340–1347

    Article  CAS  PubMed  Google Scholar 

  • Corbin KD, Zeisel SH (2012) Choline metabolism provides novel insights into non-alcoholic fatty liver disease and its progression. Curr Opin Gastroenterol 28(2):159

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Crost EH, Tailford LE, Le Gall G, Fons M, Henrissat B, Juge N (2013) Utilisation of mucin glycans by the human gut symbiont ruminococcus gnavus is strain-dependent. PLoS One 8(10):e76341

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Crow JR, Davis SL, Chaykosky DM, Smith TT, Smith JM (2015) Probiotics and fecal microbiota transplant for primary and secondary prevention of C lostridium difficile infection. Pharmacother: J Hum Pharmacol Drug Ther 35(11):1016–1025

    Article  CAS  Google Scholar 

  • Cuervo A, Hevia A, López P, Suárez A, Sánchez B, Margolles A, González S (2015) Association of polyphenols from oranges and apples with specific intestinal microorganisms in systemic lupus erythematosus patients. Nutrients 7(2):1301–1317

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • de Goffau MC, Luopajärvi K, Knip M, Ilonen J, Ruohtula T, Härkönen T, Orivuori L, Hakala S, Welling GW, Harmsen HJ (2013) Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes 62(4):1238–1244

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Derrien M, Vaughan EE, Plugge CM, de Vos WM (2004) Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol 54(5):1469–1476

    Article  CAS  PubMed  Google Scholar 

  • Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB (2012) Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/− mice. Nature 487(7405):104

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Diamant M, Blaak E, De Vos W (2011) Do nutrient–gut–microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev 12(4):272–281

    Article  CAS  PubMed  Google Scholar 

  • Dicksved J, Halfvarson J, Rosenquist M, Järnerot G, Tysk C, Apajalahti J, Engstrand L, Jansson JK (2008) Molecular analysis of the gut microbiota of identical twins with Crohn’s disease. ISME J 2(7):716

    Article  CAS  PubMed  Google Scholar 

  • Dobbs S, Dobbs R, Weller C, Charlett A (2000) Link between helicobacter pylori infection and idiopathic parkinsonism. Med Hypotheses 55(2):93–98

    Article  CAS  PubMed  Google Scholar 

  • Dumas M-E, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A, Fearnside J, Tatoud R, Blanc V, Lindon JC (2006) Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci 103(33):12511–12516

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Duncan SH, Lobley G, Holtrop G, Ince J, Johnstone A, Louis P, Flint HJ (2008) Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes 32(11):1720

    Article  CAS  Google Scholar 

  • Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308(5728):1635–1638

    Article  PubMed  PubMed Central  Google Scholar 

  • Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ, Peaper DR, Bertin J, Eisenbarth SC, Gordon JI (2011) NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145(5):745–757

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ermund A, Schütte A, Johansson MEV, Gustafsson JK, Hansson GC (2013) Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer’s patches. Am J Physiol Gastrointest Liver Physiol 305(5):G341–G347

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Finegold SM (2011) State of the art; microbiology in health and disease. Intestinal bacterial flora in autism. Anaerobe 17(6):367–368

    Article  PubMed  Google Scholar 

  • Frank DN, Amand ALS, Feldman RA, Boedeker EC, Harpaz N, Pace NR (2007a) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci 104(34):13780–13785

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR (2007b) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104(34):13780–13785

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Furet J-P, Kong L-C, Tap J, Poitou C, Basdevant A, Bouillot J-L, Mariat D, Corthier G, Doré J, Henegar C et al (2010) Differential adaptation of human gut microbiota to bariatric surgery–induced weight loss. Links with metabolic and low-grade inflammation markers. Diabetes 59(12):3049–3057

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J (2009) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58(7):1509–1517

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gomes AC, Bueno AA, de Souza RGM, Mota JF (2014) Gut microbiota, probiotics and diabetes. Nutr J 13(1):60

    Article  PubMed  PubMed Central  Google Scholar 

  • Goso Y, Ishihara K, Sugawara S, Hotta K (2001) Purification and characterization of α-l-fucosidases from Streptomyces sp. OH11242. Comp Biochem Physiol B: Biochem Mol Biol 130(3):375–383

    Article  CAS  Google Scholar 

  • Guo Y, Mah E, Davis C, Jalili T, Ferruzzi M, Chun O, Bruno R (2013) Dietary fat increases quercetin bioavailability in overweight adults. Mol Nutr Food Res 57:896–905

    Article  CAS  PubMed  Google Scholar 

  • Hedin CR, McCarthy NE, Louis P, Farquharson FM, McCartney S, Taylor K, Prescott NJ, Murrells T, Stagg AJ, Whelan K et al (2014) Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn’s disease and their unaffected siblings. Gut 63(10):1578–1586

    Article  CAS  PubMed  Google Scholar 

  • Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482(7384):179

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hevia A, Milani C, López P, Cuervo A, Arboleya S, Duranti S, Turroni F, González S, Suárez A, Gueimonde M et al (2014) Intestinal dysbiosis associated with systemic lupus erythematosus. MBio 5(5):e01548–e01514

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hida M, Aiba Y, Sawamura S, Suzuki N, Satoh T, Koga Y (1996) Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin®, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron 74(2):349–355

    Article  CAS  PubMed  Google Scholar 

  • Honda K, Littman DR (2012) The microbiome in infectious disease and inflammation. Annu Rev Immunol 30:759–795

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hoskins LC, Boulding ET, Larson G (1997) Purification and characterization of blood group A-degrading isoforms of α-N-acetylgalactosaminidase from ruminococcus torques strain IX-70. J Biol Chem 272(12):7932–7939

    Article  CAS  PubMed  Google Scholar 

  • Hur KY, Lee M-S (2015) Gut microbiota and metabolic disorders. Diabetes Metab J 39(3):198–203

    Article  PubMed  PubMed Central  Google Scholar 

  • Jia W, Li H, Zhao L, Nicholson JK (2008) Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov 7(2):123

    Article  CAS  PubMed  Google Scholar 

  • Jiang W, Wu N, Wang X, Chi Y, Zhang Y, Qiu X, Hu Y, Li J, Liu Y (2015) Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci Rep 5:8096

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Johansson ME, Larsson JMH, Hansson GC (2011) The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host–microbial interactions. Proc Natl Acad Sci 108(Supplement 1):4659–4665

    Article  PubMed  Google Scholar 

  • Jumpertz R, Le DS, Turnbaugh PJ, Trinidad C, Bogardus C, Gordon JI, Krakoff J (2011) Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr 94(1):58–65

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kang D-W, Park JG, Ilhan ZE, Wallstrom G, Labaer J, Adams JB, Krajmalnik-Brown R (2013) Reduced incidence of prevotella and other fermenters in intestinal microflora of autistic children. PLoS One 8(7):e68322–e68322

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kasubuchi M, Hasegawa S, Hiramatsu T, Ichimura A, Kimura I (2015) Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients 7(4):2839–2849

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, Pettersson S, Conway S (2004) Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA. Nat Immunol 5(1):104

    Article  CAS  PubMed  Google Scholar 

  • Kelly T, Yang W, Chen C-S, Reynolds K, He J (2008) Global burden of obesity in 2005 and projections to 2030. Int J Obes 32(9):1431

    Article  CAS  Google Scholar 

  • Kieffer DA, Piccolo BD, Vaziri ND, Liu S, Lau WL, Khazaeli M, Nazertehrani S, Moore ME, Marco ML, Martin RJ (2016) Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats. Am J Physiol Renal Physiol 310(9):F857–F871

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, Terasawa K, Kashihara D, Hirano K, Tani T (2013) The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun 4:1829

    Article  CAS  PubMed  Google Scholar 

  • Knights D, Parfrey LW, Zaneveld J, Lozupone C, Knight R (2011) Human-associated microbial signatures: examining their predictive value. Cell Host Microbe 10(4):292–296

    Article  CAS  PubMed  Google Scholar 

  • Kondo S, Xiao J-Z, Satoh T, Odamaki T, Takahashi S, Sugahara H, Yaeshima T, Iwatsuki K, Kamei A, Abe K (2010) Antiobesity effects of bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Biosci Biotechnol Biochem 74(8):1656–1661

    Article  CAS  PubMed  Google Scholar 

  • Krieg N, Staley J, Brown D, Hedlund B, Paster B, Ward N, Ludwig W, Whitman W (2010) Bergey’s manual of systematic bacteriology, vol 4. Springer Science+ Business Media, New York, NY

    Book  Google Scholar 

  • Kumar A, Agarwal S, Phadke SR, Jaiswal Y (2014) Genetic insight of schizophrenia: past and future perspectives. Gene 535(2):97–100

    Article  CAS  PubMed  Google Scholar 

  • Langley-Evans S (2015) Nutrition in early life and the programming of adult disease: a review. J Hum Nutr Diet 28:1–14

    Article  PubMed  Google Scholar 

  • Larsson JMH, Karlsson H, Crespo JG, Johansson ME, Eklund L, Sjövall H, Hansson GC (2011) Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation. Inflamm Bowel Dis 17(11):2299–2307

    Article  PubMed  Google Scholar 

  • Levine MJ, Reddy MS, Tabak LA, Loomis RE, Bergey EJ, Jones PC, Cohen RE, Stinson MW, Al-Hashimi I (1987) Structural aspects of salivary glycoproteins. J Dent Res 66(2):436–441

    Article  CAS  PubMed  Google Scholar 

  • Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444(7122):1022

    Article  CAS  PubMed  Google Scholar 

  • Lim GB (2015) Heart failure: gut flora—pathogenic role in chronic heart failure. Nat Rev Cardiol 13(2):61

    Article  PubMed  Google Scholar 

  • Macfarlane S, Hopkins MJ, Macfarlane GT (2001) Toxin synthesis and mucin breakdown are related to swarming phenomenon in clostridium septicum. Infect Immun 69(2):1120–1126

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mafra D, Lobo JC, Barros AF, Koppe L, Vaziri ND, Fouque D (2014) Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease. Future Microbiol 9(3):399–410

    Article  CAS  PubMed  Google Scholar 

  • Mahowald MA, Rey FE, Seedorf H, Turnbaugh PJ, Fulton RS, Wollam A, Shah N, Wang C, Magrini V, Wilson RK (2009) Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci 106(14):5859–5864

    Article  PubMed  PubMed Central  Google Scholar 

  • Malinen E, Krogius-Kurikka L, Lyra A, Nikkilä J, Jääskeläinen A, Rinttilä T, Vilpponen-Salmela T, von Wright AJ, Palva A (2010) Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World J Gastroenterol: WJG 16(36):4532

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P et al (2006) Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut 55(2):205–211

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mao Y, Nobaek S, Kasravi B, Adawi D, Stenram U, Molin G, Jeppsson B (1996) The effects of lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology 111(2):334–344

    Article  CAS  PubMed  Google Scholar 

  • Mariat D, Firmesse O, Levenez F, Guimarăes V, Sokol H, Doré J, Corthier G, Furet J (2009) The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 9(1):123

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Martínez I, Perdicaro DJ, Brown AW, Hammons S, Carden TJ, Carr TP, Eskridge KM, Walter J (2013) Diet-induced alterations of host cholesterol metabolism are likely to affect the gut microbiota composition in hamsters. Appl Environ Microbiol 79(2):516–524

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Martinez RCR, Bedani R, Saad SMI (2015) Scientific evidence for health effects attributed to the consumption of probiotics and prebiotics: an update for current perspectives and future challenges. Br J Nutr 114(12):1993–2015

    Article  CAS  PubMed  Google Scholar 

  • Matsuoka K, Kanai T (2015) The gut microbiota and inflammatory bowel disease. In: Seminars in immunopathology: 2015. Springer, Berlin, pp 47–55

    Google Scholar 

  • McPhee JB, Schertzer JD (2015) Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation. Clin Sci 129(12):1083–1096

    Article  CAS  Google Scholar 

  • Mejía-León ME, Barca AM (2015) Diet, microbiota and immune system in type 1 diabetes development and evolution. Nutrients 7(11):9171–9184

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Miklossy J (2011, Sep 20) Emerging roles of pathogens in Alzheimer disease. Expert Rev Mol Med 13:e30. https://doi.org/10.1017/S1462399411002006

  • Million M, Maraninchi M, Henry M, Armougom F, Richet H, Carrieri P, Valero R, Raccah D, Vialettes B, Raoult D (2012a) Obesity-associated gut microbiota is enriched in lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int J Obes 36(6):817–825

    Article  CAS  Google Scholar 

  • Million M, Maraninchi M, Henry M, Armougom F, Richet H, Carrieri P, Valero R, Raccah D, Vialettes B, Raoult D (2012b) Obesity-associated gut microbiota is enriched in lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int J Obes 36(6):817

    Article  CAS  Google Scholar 

  • Molloy MJ, Bouladoux N, Belkaid Y (2012) Intestinal microbiota: shaping local and systemic immune responses. In: Seminars in immunology: 2012. Elsevier, pp 58–66

    Google Scholar 

  • Moos WH, Maneta E, Pinkert CA, Irwin MH, Hoffman ME, Faller DV, Steliou K (2016) Epigenetic treatment of neuropsychiatric disorders: autism and schizophrenia. Drug Dev Res 77(2):53–72

    Article  CAS  PubMed  Google Scholar 

  • Mulak A, Bonaz B (2015) Brain-gut-microbiota axis in Parkinson’s disease. World J Gastroenterol 21(37):10609–10620

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Murri M, Leiva I, Gomez-Zumaquero JM, Tinahones FJ, Cardona F, Soriguer F, Queipo-Ortuño MI (2013) Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med 11(1):46

    Article  PubMed  PubMed Central  Google Scholar 

  • Murugesan S, Nirmalkar K, García-Espitia M, Pizano-Zárate ML, Hoyo-Vadillo C, Garcia-Mena J (2017) Current insight into the role of gut microbiota in Mexican childhood obesity. SOJ Pharm Pharm Sci 4:1–5

    Article  Google Scholar 

  • Musso G, Gambino R, Cassader M (2011) Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med 62:361–380

    Article  CAS  PubMed  Google Scholar 

  • Nicholson JK, Holmes E, Wilson ID (2005) Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol 3(5):431

    Article  CAS  PubMed  Google Scholar 

  • Nielsen HH, Qiu J, Friis S, Wermuth L, Ritz B (2012) Treatment for helicobacter pylori infection and risk of Parkinson’s disease in Denmark. Eur J Neurol 19(6):864–869

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nisbet RM, Polanco J-C, Ittner LM, Götz J (2015) Tau aggregation and its interplay with amyloid-β. Acta Neuropathol 129(2):207–220

    Article  CAS  PubMed  Google Scholar 

  • Nishikawa J, Kudo T, Sakata S, Benno Y, Sugiyama T (2009) Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis. Scand J Gastroenterol 44(2):180–186

    Article  CAS  PubMed  Google Scholar 

  • O’Mahony D, Murphy S, Boileau T, Park J, O’Brien F, Groeger D, Konieczna P, Ziegler M, Scully P, Shanahan F et al (2010) Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo. BMC Immunol 11:63–63

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • O’Toole PW, Jeffery IB (2015) Gut microbiota and aging. Science 350(6265):1214–1215

    Article  CAS  PubMed  Google Scholar 

  • Oishi K, Sato T, Yokoi W, Yoshida Y, Ito M, Sawada H (2008) Effect of probiotics, Bifidobacterium breve and lactobacillus casei, on bisphenol a exposure in rats. Biosci Biotechnol Biochem 72(6):1409–1415

    Article  CAS  PubMed  Google Scholar 

  • Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölsch UR, Timmis KN, Schreiber S (2004) Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53(5):685–693

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Patil DP, Dhotre DP, Chavan SG, Sultan A, Jain DS, Lanjekar VB, Gangawani J, Shah PS, Todkar JS, Shah S (2012) Molecular analysis of gut microbiota in obesity among Indian individuals. J Biosci 37(4):647–657

    Article  CAS  PubMed  Google Scholar 

  • Pellegrini S, Sordi V, Bolla AM, Saita D, Ferrarese R, Canducci F, Clementi M, Invernizzi F, Mariani A, Bonfanti R et al (2017a) Duodenal mucosa of patients with type 1 diabetes shows distinctive inflammatory profile and microbiota. J Clin Endocrinol Metabol 102(5):1468–1477

    Article  Google Scholar 

  • Pellegrini S, Sordi V, Bolla AM, Saita D, Ferrarese R, Canducci F, Clementi M, Invernizzi F, Mariani A, Bonfanti R (2017b) Duodenal mucosa of patients with type 1 diabetes shows distinctive inflammatory profile and microbiota. J Clin Endocrinol Metabol 102(5):1468–1477

    Article  Google Scholar 

  • Peterson DA, Frank DN, Pace NR, Gordon JI (2008) Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 3(6):417–427

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Png CW, Lindén SK, Gilshenan KS, Zoetendal EG, McSweeney CS, Sly LI, McGuckin MA, Florin TH (2010) Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 105(11):2420

    Article  CAS  PubMed  Google Scholar 

  • Pozzilli P, Signore A, Williams AJK, Beales PE (1993) NOD mouse colonies around the world- recent facts and figures. Immunol Today 14(5):193–196

    Article  CAS  PubMed  Google Scholar 

  • Prandota J (2014) Possible link between toxoplasma gondii and the anosmia associated with neurodegenerative diseases. Am J Alzheimers Dis Other Dement 29(3):205–214

    Article  Google Scholar 

  • Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490(7418):55

    Article  CAS  PubMed  Google Scholar 

  • Radilla-Vázquez RB, Parra-Rojas I, Martínez-Hernández NE, Márquez-Sandoval YF, Illades-Aguiar B, Castro-Alarcón N (2016) Gut microbiota and metabolic endotoxemia in young obese Mexican subjects. Obes Facts 9(1):1–11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rahne K-E, Tagesson C, Nyholm D (2013) Motor fluctuations and helicobacter pylori in Parkinson’s disease. J Neurol 260(12):2974–2980

    Article  PubMed  Google Scholar 

  • Raman M, Ahmed I, Gillevet PM, Probert CS, Ratcliffe NM, Smith S, Greenwood R, Sikaroodi M, Lam V, Crotty P (2013) Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 11(7):868–875. e863

    Article  CAS  PubMed  Google Scholar 

  • Reunanen J, Kainulainen V, Huuskonen L, Ottman N, Belzer C, Huhtinen H, de Vos WM, Satokari R (2015) Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer. Appl Environ Microbiol 81(11):3655–3662

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Roberton AM, Corfield AP (1999) Mucin degradation and its significance in inflammatory conditions of the gastrointestinal tract. In: Medical importance of the normal microflora. Springer, pp 222–261

    Google Scholar 

  • Robinson CV, Elkins MR, Bialkowski KM, Thornton DJ, Kertesz MA (2012) Desulfurization of mucin by Pseudomonas aeruginosa: influence of sulfate in the lungs of cystic fibrosis patients. J Med Microbiol 61(12):1644–1653

    Article  CAS  PubMed  Google Scholar 

  • Rogers G, Keating D, Young R, Wong M, Licinio J, Wesselingh S (2016) From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Mol Psychiatry 21(6):738

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rogier R, Koenders MI, Abdollahi-Roodsaz S (2015) Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritis. J Immunol Res 2015:527696–527696

    Article  PubMed  PubMed Central  Google Scholar 

  • Rojo D, Hevia A, Bargiela R, López P, Cuervo A, González S, Suárez A, Sánchez B, Martínez-Martínez M, Milani C et al (2015) Ranking the impact of human health disorders on gut metabolism: systemic lupus erythematosus and obesity as study cases. Sci Rep 5:8310–8310

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ruotolo G, Howard BV (2002) Dyslipidemia of the metabolic syndrome. Curr Cardiol Rep 4(6):494–500

    Article  PubMed  Google Scholar 

  • Sandberg MEC, Bengtsson C, Klareskog L, Alfredsson L, Saevarsdottir S (2015) Recent infections are associated with decreased risk of rheumatoid arthritis: a population-based case-control study. Ann Rheum Dis 74(5):904–907

    Article  PubMed  Google Scholar 

  • Sandek A, Bauditz J, Swidsinski A, Buhner S, Weber-Eibel J, von Haehling S, Schroedl W, Karhausen T, Doehner W, Rauchhaus M (2007) Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 50(16):1561–1569

    Article  CAS  PubMed  Google Scholar 

  • Sandhya P, Danda D, Sharma D, Scaria V (2016) Does the buck stop with the bugs?: an overview of microbial dysbiosis in rheumatoid arthritis. Int J Rheum Dis 19(1):8–20

    Article  PubMed  Google Scholar 

  • Sanz Y (2010) Effects of a gluten-free diet on gut microbiota and immune function in healthy adult humans. Gut Microbes 1(3):135–137

    Article  PubMed  PubMed Central  Google Scholar 

  • Sato J, Kanazawa A, Ikeda F, Yoshihara T, Goto H, Abe H, Komiya K, Kawaguchi M, Shimizu T, Ogihara T et al (2014) Gut dysbiosis and detection of “live gut bacteria” in blood of Japanese patients with type 2 diabetes. Diabetes Care 37(8):2343–2350

    Article  CAS  PubMed  Google Scholar 

  • Saulnier DM, Gibson GR, Kolida S (2008) In vitro effects of selected synbiotics on the human faecal microbiota composition. FEMS Microbiol Ecol 66(3):516–527

    Article  CAS  PubMed  Google Scholar 

  • Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M (2015) Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord 30(3):350–358

    Article  PubMed  Google Scholar 

  • Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, Rostron T, Cerundolo V, Pamer EG, Abramson SB et al (2013) Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. elife 2:e01202–e01202

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schultsz C, van den Berg FM, Fiebo W, Tytgat GN, Dankert J (1999) The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology 117(5):1089–1097

    Article  CAS  PubMed  Google Scholar 

  • Schwabe RF, Jobin C (2013) The microbiome and cancer. Nat Rev Cancer 13(11):800

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sellitto M, Bai G, Serena G, Fricke WF, Sturgeon C, Gajer P, White JR, Koenig SSK, Sakamoto J, Boothe D et al (2012) Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS One 7(3):e33387–e33387

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Serino M, Fernández-Real JM, García-Fuentes E, Queipo-Ortuño M, Moreno-Navarrete JM, Sánchez A, Burcelin R, Tinahones F (2013) The gut microbiota profile is associated with insulin action in humans. Acta Diabetol 50(5):753–761

    Article  CAS  PubMed  Google Scholar 

  • Serre CBL, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE (2010) Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 299(2):G440–G448

    Article  CAS  Google Scholar 

  • Sheridan PO, Bindels LB, Saulnier DM, Reid G, Nova E, Holmgren K, O’Toole PW, Bunn J, Delzenne N, Scott KP: Can prebiotics and probiotics improve therapeutic outcomes for undernourished individuals?; 201474-82

    Google Scholar 

  • Shin N-R, Lee J-C, Lee H-Y, Kim M-S, Whon TW, Lee M-S, Bae J-W (2014) An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63(5):727–735

    Article  CAS  PubMed  Google Scholar 

  • Silberberg D, Anand NP, Michels K, Kalaria RN (2015) Brain and other nervous system disorders across the lifespan — global challenges and opportunities. Nature 527:S151

    Article  CAS  PubMed  Google Scholar 

  • Sipos F, Leiszter K, Tulassay Z (2011) Effect of ageing on colonic mucosal regeneration. World J Gastroenterol: WJG 17(25):2981

    Article  PubMed  PubMed Central  Google Scholar 

  • Sokol H, Cosnes J, Chazouilleres O, Beaugerie L, Tiret E, Poupon R, Seksik P (2008) Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. World J Gastroenterol: WJG 14(22):3497

    Article  PubMed  PubMed Central  Google Scholar 

  • Sommer F, Bäckhed F (2013) The gut microbiota—masters of host development and physiology. Nat Rev Microbiol 11(4):227

    Article  CAS  PubMed  Google Scholar 

  • Song X, Fan X, Song X, Zhang J, Zhang W, Li X, Gao J, Harrington A, Ziedonis D, Lv L (2013) Elevated levels of adiponectin and other cytokines in drug naive, first episode schizophrenia patients with normal weight. Schizophr Res 150(1):269–273

    Article  PubMed  Google Scholar 

  • Spencer MD, Hamp TJ, Reid RW, Fischer LM, Zeisel SH, Fodor AA (2011) Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 140(3):976–986

    Article  CAS  PubMed  Google Scholar 

  • Stewart-Tull D, Ollar R, SCOBIE TS (1986) Studies on the vibrio cholerae mucinase complex. I. Enzymic activities associated with the complex325. J Med Microbiol 22(4):325–333

    Article  CAS  PubMed  Google Scholar 

  • Sun J, Chang EB (2014) Exploring gut microbes in human health and disease: pushing the envelope. Genes Dis 1(2):132–139

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tailford LE, Crost EH, Kavanaugh D, Juge N (2015) Mucin glycan foraging in the human gut microbiome. Front Genet 6:81

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tap J, Mondot S, Levenez F, Pelletier E, Caron C, Furet JP, Ugarte E, Muñoz-Tamayo R, Paslier DL, Nalin R (2009) Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 11(10):2574–2584

    Article  PubMed  Google Scholar 

  • Tilg H, Moschen AR (2014) Microbiota and diabetes: an evolving relationship. Gut 63(9):1513–1521

    Article  CAS  PubMed  Google Scholar 

  • Tlaskalová-Hogenová H, Stěpánková R, Kozáková H, Hudcovic T, Vannucci L, Tučková L, Rossmann P, Hrnčíř T, Kverka M, Zákostelská Z et al (2011) The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol 8(2):110–120

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tomova A, Husarova V, Lakatosova S, Bakos J, Vlkova B, Babinska K, Ostatnikova D (2015) Gastrointestinal microbiota in children with autism in Slovakia. Physiol Behav 138:179–187

    Article  CAS  PubMed  Google Scholar 

  • Tong M, Li X, Wegener Parfrey L, Roth B, Ippoliti A, Wei B, Borneman J, McGovern DPB, Frank DN, Li E et al (2013) A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease. PLoS One 8(11):e80702–e80702

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Toshikuni N, Tsutsumi M, Arisawa T (2014) Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease. World J Gastroenterol: WJG 20(26):8393

    Article  PubMed  PubMed Central  Google Scholar 

  • Tuohy KM, Fava F, Viola R (2014) ‘The way to a man’s heart is through his gut microbiota’–dietary pro-and prebiotics for the management of cardiovascular risk. Proc Nutr Soc 73(2):172–185

    Article  CAS  PubMed  Google Scholar 

  • Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP (2009) A core gut microbiome in obese and lean twins. Nature 457(7228):480

    Article  CAS  PubMed  Google Scholar 

  • Vaahtovuo J, Munukka E, Korkeamäki M, Luukkainen R, Toivanen P (2008) Fecal microbiota in early rheumatoid arthritis. J Rheumatol 35(8):1500–1505

    CAS  PubMed  Google Scholar 

  • Veerappan G, Betteridge J, Young P (2012) Probiotics for the treatment of inflammatory bowel disease. Curr Gastroenterol Rep 14:324–333

    Article  PubMed  Google Scholar 

  • Verdam FJ, Fuentes S, de Jonge C, Zoetendal EG, Erbil R, Greve JW, Buurman WA, de Vos WM, Rensen SS (2013) Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity 21(12):E607–E615

    Article  CAS  PubMed  Google Scholar 

  • Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE, Gewirtz AT (2010) Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science 328(5975):228–231

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vindigni SM, Zisman TL, Suskind DL, Damman CJ (2016) The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Ther Adv Gastroenterol 9(4):606–625

    Article  CAS  Google Scholar 

  • Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, Rayment N, Brostoff J, Parkhill J, Dougan G, Petrovska L (2011) High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol 11:7–7

    Article  PubMed  PubMed Central  Google Scholar 

  • Wallace BD, Redinbo MR (2013) The human microbiome is a source of therapeutic drug targets. Curr Opin Chem Biol 17(3):379–384

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Walters WA, Xu Z, Knight R (2014) Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett 588(22):4223–4233

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang I-K, Lai H-C, Yu C-J, Liang C-C, Chang C-T, Kuo H-L, Yang Y-F, Lin C-C, Lin H-H, Liu Y-L (2012) Real-time PCR analysis of the intestinal microbiotas in peritoneal dialysis patients. Appl Environ Microbiol 78(4):1107–1112

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang W, Chen L, Zhou R, Wang X, Song L, Huang S, Wang G, Xia B (2014) Increased proportions of bifidobacterium and the lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol 52(2):398–406

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP (2013) Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One 8(8):e70803

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA et al (2008) Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455(7216):1109–1113

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • West CE, Jenmalm M, Prescott S (2015) The gut microbiota and its role in the development of allergic disease: a wider perspective. Clin Exp Allergy 45(1):43–53

    Article  CAS  PubMed  Google Scholar 

  • Wexler HM (2007) Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev 20(4):593–621

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, Järnerot G, Tysk C, Jansson JK, Engstrand L (2010) A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Commentary. Gastroenterology 139(6):1844–1854. e1

    Article  Google Scholar 

  • Winer DA, Luck H, Tsai S, Winer S (2016) The intestinal immune system in obesity and insulin resistance. Cell Metab 23(3):413–426

    Article  CAS  PubMed  Google Scholar 

  • Wing MR, Patel SS, Ramezani A, Raj DS (2016) Gut microbiome in chronic kidney disease. Exp Physiol 101(4):471–477

    Article  CAS  PubMed  Google Scholar 

  • Woting A, Blaut M (2016) The intestinal microbiota in metabolic disease. Nutrients 8(4):202

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET (2000) Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatr 157(1):16–25

    Article  CAS  PubMed  Google Scholar 

  • Wu C-C, Weng W-L, Lai W-L, Tsai H-P, Liu W-H, Lee M-H, Tsai Y-C (2015) Effect of lactobacillus plantarum strain K21 on high-fat diet-fed obese mice. Evid Based Complement Alternat Med 2015

    Google Scholar 

  • Xu J, Gordon JI (2003) Honor thy symbionts. Proc Natl Acad Sci 100(18):10452–10459

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yang J-Y, Kweon M-N (2016) The gut microbiota: a key regulator of metabolic diseases. BMB Rep 49(10):536

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP (2012) Human gut microbiome viewed across age and geography. Nature 486(7402):222

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yeoh N, Burton J, Suppiah P, Reid G, Stebbings S (2013) The role of the microbiome in rheumatic diseases. Curr Rheumatol Rep 15:314

    Article  CAS  PubMed  Google Scholar 

  • Yolken R, Dickerson F (2014) The microbiome-the missing link in the pathogenesis of schizophrenia. Schizophr Res 153:S16

    Article  PubMed Central  Google Scholar 

  • Zeng MY, Cisalpino D, Varadarajan S, Hellman J, Warren HS, Cascalho M, Inohara N, Núñez G (2016) Gut microbiota-induced immunoglobulin G controls systemic infection by symbiotic bacteria and pathogens. Immunity 44(3):647–658

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang X, Shen D, Fang Z, Jie Z, Qiu X, Zhang C, Chen Y, Ji L (2013) Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One 8(8):e71108–e71108

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang M, Fan X, Fang B, Zhu C, Zhu J, Ren F (2015) Effects of lactobacillus salivarius Ren on cancer prevention and intestinal microbiota in 1, 2-dimethylhydrazine-induced rat model. J Microbiol 53(6):398–405

    Article  PubMed  Google Scholar 

  • Zhu L, Baker SS, Gill C, Liu W, Alkhouri R, Baker RD, Gill SR (2013) Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 57(2):601–609

    Article  CAS  PubMed  Google Scholar 

  • Zigra P, Maipa V, Alamanos Y (2008) Probiotics and remission of ulcerative colitis: a systematic review. Neth J Med 65:411–418

    Google Scholar 

Download references

Acknowledgements

The work was supported by the financial assistance from the extramural research grant of Indian Council of Medical Research (ICMR), Second Phase of Biomedical Informatics Centres of ICMR Grant Number: BIC/12(19)/2013. The Authors acknowledge Department of Science and Technology, Government of India, New Delhi, for granting inspire fellowship to Mr. Ardhendu Bhusan Praharaj. The authors also acknowledge ICMR-Regional Medical Research Centre, Bhubaneswar for providing infrastructure facilities to carry out this work.

Conflict of Interest Disclosure

The authors declare no conflict of interest exists.

Declaration of Funding Sources

The work was supported by the financial assistance from the extramural research grant of Indian Council of Medical Research (ICMR), Second Phase of Biomedical Informatics Centres of ICMR Grant Number: BIC/12(19)/2013 and DST, Govt. of India.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Behera, S.K., Praharaj, A.B., Chalikonda, G., Srivani, G., Mahapatra, N. (2020). Gut Microbiota as Signatures in Non-communicable Diseases and Mucosal Immunity. In: Raju, G., Bhaskar, L. (eds) Theranostics Approaches to Gastric and Colon Cancer. Diagnostics and Therapeutic Advances in GI Malignancies. Springer, Singapore. https://doi.org/10.1007/978-981-15-2017-4_11

Download citation

Publish with us

Policies and ethics